Acute Telogen Effluvium: A Post-Covid-19 Sequela

April 2023 in “ Clinical dermatology review ”

Mohan Eshwar Rao Shendre, Sanjay Ramachandra Thejaswi, Chanabasappa Mendagudli, Vrinda Nair, Supriya Rajesh

telogen effluvium hair loss COVID-19 excessive shedding thinning of hair scalp TE

TLDR COVID-19 infection may cause hair loss.

The study "Acute Telogen Effluvium: A Post-COVID-19 Sequela" conducted a cross-sectional survey of 114 COVID-19-positive patients in South India to investigate the presence of hair loss post-infection. The results showed that 72% of the patients reported hair loss, with 54.4% noticing worsening hair loss after COVID-19 infection. The majority (66.7%) noticed worsening hair loss after 3 weeks of infection. The study also found that 61.4% of the patients reported excessive shedding of hair and 51.8% experienced thinning of hair over the scalp. The study concluded that COVID-19 infection could be a potential cause of hair loss, and recognizing this could help in educating patients about the transient nature of the condition. However, the study did not follow up with patients for recovery from Telogen Effluvium (TE).

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations, December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations, August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations, July 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations, January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Telogen Effluvium: A Sequela of COVID-19

58 citations, November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations, November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations, May 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research An Overview of Alopecias

53 citations, March 2014 in “Cold Spring Harbor Perspectives in Medicine”

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

research Diffuse Hair Loss in an Adult Female: Approach to Diagnosis and Management

70 citations, January 2009 in “Indian Journal of Dermatology, Venereology and Leprology”

To manage hair loss in adult women, find the cause and treat it accordingly.

Similar Research

5 / 1000+ results

research Unraveling The Psychological Impact Of Telogen Effluvium: Understanding Hair Loss Beyond The Scalp

March 2024 in “Buletin de psihiatrie integrativă (Print)”

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies

3 citations, August 2022 in “International Journal of Molecular Sciences”

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Post-COVID Telogen Effluvium: The Diagnostic Value of Serum Ferritin Biomarker and the Preventive Value of Dietary Supplements. A Case-Control Study

research Post-COVID Telogen Effluvium: The Diagnostic Value of Serum Ferritin Biomarker and the Preventive Value of Dietary Supplements. A Case-Control Study

June 2024 in “Archives of dermatological research”

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

research Hair Loss in Women: Causes and Treatments

May 2022 in “Journal of the Egyptian Women's Dermatologic Society (Print)”

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

research Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases

May 2023 in “Journal of Clinical Medicine”

New understanding and treatments for hair loss are improving, but more research is needed.